Zeneca boosted by US approval for new breast cancer drug
Wednesday 03 January 1996
Zeneca took another step towards its goal of being the world's largest cancer drug group yesterday when it received clearance from the American Food and Drug Administration to market Arimidex, a new treatment for advanced breast cancer in post-menopausal women.
Analysts welcomed the final approval, which could lead to peak sales of Arimidex in perhaps five years of pounds 260m, a sizeable contribution to the company's pharmaceutical sales, just over pounds 2bn last year and forecast to reach pounds 3.3bn by 2000. The shares closed 6p higher at 1,252p.
Tom McKillop, chief executive of Zeneca's pharmaceuticals arm, said: "Current hormonal therapies for advanced breast cancer have limitations, particularly in terms of patient acceptability. Arimidex represents an effective and well-tolerated therapy."
He added that Zeneca, headed by David Barnes, would be evaluating the use of the drug in the treatment of early breast cancer, a much larger market. According to the American Cancer Society, an estimated 184,300 women will be diagnosed with breast cancer in 1996. Zeneca believes that, despite screening campaigns to detect the disease in its early stages, 18,000 women in the US have advanced breast cancer.
About one woman in eight is expected to develop breast cancer at some time in her lifetime. The market for hormonal therapies to treat breast cancer in America was valued at $300m in 1994. Arimidex is effective because of the way it counters the growth of tumours stimulated by the female hormone oestrogen. In post-menopausal women, one of the main targets for anti-cancer drugs is non-ovarian synthesis of oestrogen, a process that Arimidex blocks.
Zeneca has already submitted Arimidex for approval in all the main drugs markets around the world. The treatment is already available in the UK and further approvals are expected this year. The company generates about a third of its revenues from cancer treatments, which include Nolvadex, another breast cancer drug, which had sales in 1994 of pounds 350m. Approval was also received last October for Casodex, which combats advanced prostate cancer. Tomudex, the first new colorectal cancer treatment for 35 years, is expected to be launched in the UK in the first quarter of the year.
The good news on Arimidex comes hot on the heels of Zeneca's announcement just before Christmas that it planned a sharp increase in its spending on drugs research and development.
According to Peter Doyle, group research and development director, R&D spending ofabout pounds 550m a year, will grow faster than inflation and the proportion of group funds spent on drugs rather than agrochemicals will increase to about two thirds.
Children's bookseller wins The Independent's new author search
Board creates magnetic field to achieve lift
Company reveals $542m investment in start-up building 'a rocket ship for the mind'
Singer says the track was 'force-fed down people's throats'
- 1 Jack the Ripper: Scientist who claims to have identified notorious killer has 'made serious DNA error'
- 2 Banksy arrest hoax: Internet duped by fake online report claiming artist's identity has been revealed
- 3 Former East 17 frontman Brian Harvey turns up at Downing Street and 'demands to speak to Prime Minister'
- 4 The inventor of the Facebook 'like' button says he never made a 'dislike' button because he feared the 'unfortunate consequences'
- 5 Russell Brand threatened with arrest after filming outside Fox News headquarters
Jack the Ripper: Scientist who claims to have identified notorious killer has 'made serious DNA error'
Oscar de la Renta dead: Legendary US fashion designer dies after long cancer battle aged 82
Oscar Pistorius: The brutal prison life that awaits disgraced athlete
Banksy arrest hoax: Internet duped by fake online report claiming artist's identity has been revealed
Super-sized ships arrive in Britain: How big can they get?
Cameron is warned 'no possibility' of UK reducing immigration and that bid to bring in quota on migrant workers would be illegal
Residents should throw a street party and mix with immigrant neighbours, councils told
Russell Brand threatened with arrest after filming outside Fox News headquarters
London bus driver 'kicks gay couple off for kissing'
Lord Freud: Tory welfare minister apologises after saying disabled people are 'not worth’ the minimum wage
Lord Freud hangs on as MPs of all parties 'call for his head' over disability comments
iJobs Money & Business
£23000 per annum + pension and 22 days holiday: Ashdown Group: An established ...
£27000 per annum + pension, 22 days holiday: Ashdown Group: An established ind...
£23000 - £26000 Per Annum: Clearwater People Solutions Ltd: Our client is curr...
£25 - 30k: Guru Careers: A Corporate Actions Administrator / Operations Admini...